DB Wealth Management Group’s Gilead Sciences GILD Stock Holding History

DB Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.16K	Hold	39	–	–	﹤0.01%	338
2023 Q3	$2.92K	Hold	39	–	–	﹤0.01%	332
2023 Q2	$3.01K	Hold	39	–	–	﹤0.01%	331
2023 Q1	$3.24K	Hold	39	–	–	﹤0.01%	322
2022 Q4	$3.35K	Buy	+39	New	+$3.09K	﹤0.01%	317
2022 Q1	–	Sell	-39	Closed	-$3K	–	339
2021 Q4	$3K	Hold	39	–	–	﹤0.01%	325
2021 Q3	$3K	Hold	39	–	–	﹤0.01%	314
2021 Q2	$3K	Hold	39	–	–	﹤0.01%	315
2021 Q1	$3K	Hold	39	–	–	﹤0.01%	327
2020 Q4	$2K	Buy	+39	New	+$2.35K	﹤0.01%	336

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DB Wealth Management Group's GILD Position: Q4 2023 in Review

DB Wealth Management Group held its Gilead Sciences (GILD) position steady in Q4 2023 at 39 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #338.

DB Wealth Management Group first reported a position in GILD in Q4 2020 and has held it in 10 quarters since. The position peaked at $3.35K in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

DB Wealth Management Group held 39 shares of Gilead Sciences worth $3.16K as of Q4 2023.
DB Wealth Management Group left its Gilead Sciences share count unchanged in Q4 2023.
Gilead Sciences made up ﹤0.01% of DB Wealth Management Group's portfolio in Q4 2023, its #338 holding.
DB Wealth Management Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 10 quarters since.
DB Wealth Management Group's Gilead Sciences position peaked at $3.35K in Q4 2022.
1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.